Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Jun 29
 +8.08 / +2.38%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 479.00, with a high estimate of 668.00 and a low estimate of 325.00. The median estimate represents a +37.70% increase from the last price of 347.86.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.24%
Growthannually -7.23%


Growthquarterly 3.58%
Growthannually 24.39%
Key to the earnings and sales forecast charts.